Not Tagged
Not Tagged
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'leusm', 'mds', 'leukemia']
#asco23 is over, but the research into #cd47 is ongoing: could a cd47 blockade potentially restore phagocytosis, which may lead to t-cell activation? register to learn more at #aml #mds #leusm #leukemia
Gilead Sciences is committed to researching innovative therapies for patients with MDS. 
© 2021 Gilead Sciences, Inc. All rights reserved. US-UNBP-0191 09/21